78.5 F
San Fernando
Saturday, Aug 13, 2022
-Advertisement-

Countersuit Filed Against Amgen

Ariad Pharmaceuticals Inc. has filed a counter claim against the Thousand Oaks drug maker Amgen Inc charging patent infringement. The suit, which was also filed against the drug maker Wyeth, is in response to an action filed by Amgen against Cambridge, Mass.-based Ariad that alleged the company’s claims to the patent are untrue. The patent concerns method of treating human disease by regulating a certain cell-signaling process.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-